Evidence map›Paper›PMID 31676728›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization?

Jorge R Barrio, Sung-Cheng Huang, Nagichettiar Satyamurthy, Claudio S Scafoglio, Amy S Yu, Abass Alavi, Kenneth A Krohn

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Sex differences in brain glucose metabolism and Alzheimer's disease risk and progression.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  6. Review
  7. Article
  8. Resistance to neoadjuvant chemotherapy in breast cancers: a metabolic perspective.Journal of experimental & clinical cancer research : CR · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. MappingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Quantitation of dynamic total-body PET imaging: recent developments and future perspectives.European journal of nuclear medicine and molecular imaging · 2023
    Review
  20. Superiority of [European journal of nuclear medicine and molecular imaging · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jorge R BarrioDepartment of Molecular and Medical Pharmacology, David Geffen UCLA School of Medicine, Los Angeles, California jbarrio@mednet.ucla.edu krohke@ohsu.edu.
Sung-Cheng HuangDepartment of Molecular and Medical Pharmacology, David Geffen UCLA School of Medicine, Los Angeles, California.
Nagichettiar SatyamurthyDepartment of Molecular and Medical Pharmacology, David Geffen UCLA School of Medicine, Los Angeles, California.
Claudio S ScafoglioDepartment of Medicine, David Geffen UCLA School of Medicine, Los Angeles, California.
Amy S YuDepartment of Molecular and Medical Pharmacology, David Geffen UCLA School of Medicine, Los Angeles, California.
Abass AlaviUniversity of Pennsylvania, Philadelphia, Pennsylvania; and.
Kenneth A KrohnOregon Health and Science University, Portland, Oregon jbarrio@mednet.ucla.edu krohke@ohsu.edu.
University of California, Los Angeles · USOregon Health & Science University · USUniversity of Pennsylvania · US

Funding

RadiochemistryP01CA042045 · NCI · UNIVERSITY OF WASHINGTON · PI EARY, JANET F. · 1986 to 2015
$23.2M
VISUALIZING BRAIN A-BETA, TAU /SEROTONIN RECEPTOR DENSITP01AG025831 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SMALL, GARY WILLIAM · 2005 to 2010
$7.0M
Investigating the heterogeneity of glucose transport in lung adenocarcinomaR01CA237401 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCAFOGLIO, CLAUDIO · 2020 to 2025
$3.1M
Role of SGLTs in Glucose Homeostasis and Tissue MetabolismR01DK077133 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WRIGHT, ERNEST M · 2008 to 2011
$1.3M
NCI NIH HHS P01 CA042045NCI NIH HHS R01 CA237401NIA NIH HHS P01 AG025831NIDDK NIH HHS R01 DK077133
6 · The paper itself

Abstract

2-Deoxy-2-

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsBlood-Brain BarrierBrainGlucoseGlucose Transporter Type 1GlycolysisHumansNeoplasmsPositron-Emission TomographySodium-Glucose Transport ProteinsFluorodeoxyglucose F18GlucoseGlucose Transporter Type 1RadiopharmaceuticalsSLC2A1 protein, humanSodium-Glucose Transport ProteinsFDG PETlumped constantSGLTs

Identifiers

PMID31676728
PMCPMC7818046
OpenAlexW2989407119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.